Experiment 67561
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | AERSSENS,J: RAEYMAEKERS,P: LILIENFELD,S: GEERTS,H: KONINGS,F: PARYS,W:. (2001). APOE GENOTYPE: NO INFLUENCE ON GALANTAMINE TREATMENT EFFICACY NOR ON RATE OF DECLINE IN ALZHEIMER'S DISEASE.. 12(2) |
| Amount utilized | |
| Compound isolated | |
| Disease | 4 INDEPENDENT DOUBLE-BLIND, PLACEBO-CONTROLLED INTERNATIONAL MULTICENTER CLINICAL TRIALS EVALUATED THE EFFICACY OF SABELUZOLE OR GALANTAMINE IN ALZHEIMER'S PATIENTS WITH APOLIPOPROTEIN E GENOTYPE. GALANTAMINE DOSE RANGED FROM 24-32 MG/DAY. GALANTAMINE PRODUCED COGNITIVE AND FUNCTIONAL IMPROVEMENT THAT WERE NOT AFFECTED BY EPSILON4 ALLELE COUNT. |
| Dose amount | VAR |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |